Why infant formula hopeful Jatenergy Ltd (ASX:JAT) surged higher today

One of the best performers on the market on Friday has been the Jatenergy Ltd (ASX: JAT) share price.

At one stage the infant formula hopeful’s shares were up as much as 10% to 4.5 cents.

Its shares have since given back a good portion of these gains and sit 5% higher at 4.3 cents ahead of the market close.

Why did Jatenergy’s shares rocket higher today?

This afternoon the company announced that its 51% owned subsidiary, Golden Koala Group, has completed the manufacture of a container load of newly formulated English label infant, follow-on, and toddler formula.

According to the release, these products are now on sale in Australia through local supermarket and pharmacies, and to Chinese families through daigou groups and cross-border and online-to-offline sales channels.

While this doesn’t seem like much to get excited about, it is worth noting that there had been concerns that there may be production problems after its manufacturer Nutritional Choice Australia fell into administration. So, seeing a container load of product will no doubt be quite a relief for shareholders.

But it isn’t all positive. Strangely, the market appears to have overlooked the second part of today’s announcement.

Management has advised that the company and AustAgri Pty Limited have mutually agreed to terminate the supply agreement they entered into in August.

That five-year supply agreement was to allow AustAgri to sell the Golden Koala infant formula product in mainland China, Hong Kong, Macau, and Taiwan, as well as through e-commerce platforms upon receipt of its CFDA accreditation.

The company advised that over the five-year period AustAgri must order a minimum amount of its 900g tins equating to sales of approximately $98 million.

At the time I questioned the viability of the deal given the limited track record of AustAgri, which had only been on the Australian Business Register since March of this year. It appears I was right to be doubtful.

Though, it is worth noting that the two parties have agreed to hold discussions regarding a possible replacement arrangement.

What now?

While I can’t blame investors for trying to find the next A2 Milk Company Ltd (ASX: A2M) or Bellamy’s Australia Ltd (ASX: BAL), I wouldn’t count on it being Jatenergy unfortunately.

Instead of gambling on Jatenergy I would be buying this top stock that has been tipped to be a market-beater.

Top Australian Stock Picker Just Issued Rare “Double Down” Buy Alert

Discover why this legendary Australian stock-picker just issued a “Double Down” buy alert to his exclusive group of insiders… and why he’s convinced this might be the single most attractive entry point for years to come.

Simply click here to get started and access our secure sign-up page.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!